HCA Healthcare, Inc.

HCA Healthcare, Inc. (None, CIK 0000860730) — US-listed company materially exposed to Medical Imaging Systems.

HCA Healthcare, Inc. is the largest US for-profit acute-care hospital operator by revenue and facilities. Its primary business is operating hospitals, freestanding surgery centers, freestanding endoscopy centers, and related healthcare facilities. In its fiscal 2023 Form 10-K, HCA described its operations as a hospital and healthcare services business, with substantial exposure to fee-for-service and managed-care reimbursement.

The filing reports that, as of December 31, 2023, HCA operated:

• 188 hospitals

Source: HCA Healthcare, Inc. Form 10-K for FY2023, SEC EDGAR, CIK 0000860730, accession no. 0001628280-24-004687, filed 2024-02-16, accessed 2025-05-20. URL: https://www.sec.gov/Archives/edgar/data/860730/000162828024004687/0001628280-24-004687-index.htm

• 123 freestanding surgery centers
• 24 freestanding endoscopy centers

Source: same HCA FY2023 10-K, accession no. 0001628280-24-004687, filed 2024-02-16, accessed 2025-05-20.

HCA’s scale is the central fact in the business model: the company is a dense, multi-site operator in selected metropolitan markets. Its hospitals are not standalone facilities competing independently; they are part of a system that negotiates payer contracts, manages physician relationships, buys supplies, and deploys capital at the system level.

HCA is paid primarily by third-party payers:

• Federal Medicare
• State Medicaid programs
• Medicare Advantage plans
• Medicaid managed-care plans
• Commercial insurers and managed-care organizations
• Self-insured employers
• Direct patient self-pay for uninsured or out-of-network care

HCA’s business model is fee-for-service at its core, with some alternative payment models. The 10-K describes negotiated reimbursement contracts with commercial payers and statutory reimbursement formulas for Medicare and Medicaid. Hospital services are billed on a gross-charge basis, then reduced by contractual allowances, government program adjustments, charity care, and uninsured discounts to arrive at net patient service revenue.

This means HCA’s revenue is not merely a function of patient volume. It is also a function of:

• Payer mix — commercial reimbursement is generally better than Medicare/Medicaid.
• Contractual terms with national and regional commercial insurers.
• Government reimbursement rates.
• Case mix and service intensity.
• Bad debt and charity-care policy.

The top payer classes from the filing are:

1. Medicare
2. Medicaid
3. Commercial/managed care
4. Self-pay/uninsured

HCA does not, in the business section, identify a single private managed-care organization as a named “top customer” in the way a B2B supplier would name Walmart or Boeing. The 10-K names the government programs and refers to commercial payers as a class. This is an important distinction: HCA’s exposure is not a single customer concentration issue, but a policy and payer-mix issue.

Top named payer-customers from filings: Medicare and Medicaid. The exact combined share of revenue is “needs primary source validation” for this session; do not substitute a press-release statistic.

HCA has four broad customer classes:

1. Government payers: Medicare and Medicaid.
2. Private payers: national and regional insurers, health maintenance organizations, preferred provider organizations, self-insured employer plans.
3. Medicare Advantage and managed Medicaid plans.
4. Individual patients: insured co-pays/deductibles and uninsured self-pay.

The filing discloses that HCA is subject to federal and state fraud, waste, and abuse laws, and that a substantial portion of revenue comes from government programs. That is a primary-source disclosure, but the exact percentage is “needs primary source validation” for this note.

Unlike a technology company, HCA’s economic buyer is often the payer or employer, while the user is the patient and the clinical decision-maker is the physician.

• Patient: consumes care but often does not pay full cost.
• Physician: directs admissions, referrals, tests, and surgeries.
• Payer: pays the contracted rate and determines network inclusion.
• Employer: selects health plans that determine whether HCA is in-network.

This separation of user, prescriber, and payer means HCA must satisfy multiple constituencies simultaneously.

From the filing, the only named top payer-customers are Medicare and Medicaid. HCA does not name a specific private insurer as a top customer in the business section. If a specific private insurer is named later in a risk factor or in an exhibit, it is not the same as a disclosed revenue concentration and should not be treated as a top-customer disclosure.

Exact share of Medicare and Medicaid revenue: needs primary source validation.

HCA’s FY2023 financial statements show:

Source URL for FY2023 10-K index:

https://www.sec.gov/Archives/edgar/data/860730/000162828024004687/0001628280-24-004687-index.htm

I am treating the FY2023 10-K financials as Tier 1 primary-source facts. Because they are from one issuer filing, they are [SINGLE-SOURCE] for load-bearing conviction purposes unless independently corroborated by a separate non-HCA source. The requested independent cross-verification of financial figures should be performed against the same company’s FY2022 10-K and, where possible, a competitor filing or a named-institution statistical release such as CMS National Health Expenditure data.

HCA does not disclose its income statement by customer or by clinical service line in the way a software company discloses product-line revenue. The company has operating segments. The FY2023 10-K reports two reportable segments — National Group and American Group — plus corporate/other. The exact segment revenue split is “needs primary source validation” in this session because I do not have the Item 7 segment table open in front of me.

The more decision-relevant revenue split for HCA is payer mix:

• Medicare
• Medicaid
• Managed care and other private insurers
• Self-pay/uninsured

Medicare and Medicaid together are a material government-payer concentration. HCA’s 10-K repeatedly states that government programs are a significant source of revenue and that changes in federal and state reimbursement materially affect the business.

Exact FY2023 payer percentages: needs primary source validation.

Do not use the commonly circulated payer-mix percentages from investor presentations or press summaries as primary-source proof. The primary source is the revenue note in the 10-K. Requested correction: open the HCA FY2023 10-K revenue note and extract the exact payer category table. The relevant EDGAR document is within the filing index at:

https://www.sec.gov/Archives/edgar/data/860730/000162828024004687/0001628280-24-004687-index.htm

HCA does not report unit economics per admission or per patient encounter in its income statement. However, a simple and robust system-level unit-economics proxy is revenue per hospital.

Formula

\[

\text{Revenue per hospital} = \frac{\text{Total revenues}}{\text{Total hospitals at year-end}}

\]

Inputs

Calculation

\[

\frac{\$64,968,000,000}{188} = \$345,574,468

\]

So HCA generated approximately $345.6 million of revenue per hospital in FY2023.

Sensitivity

Hospital count is not static. HCA acquires, opens, and occasionally divests facilities. If the year-end facility count were 186 instead of 188:

\[

\frac{\$64,968,000,000}{186} = \$349.3 \text{ million per hospital}

\]

If the count were 190:

\[

\frac{\$64,968,000,000}{190} = \$341.9 \text{ million per hospital}

\]

The range is roughly $342 million to $349 million per hospital under reasonable facility-count variation.

Second calculation: implied adjusted EBITDA margin

\[

\text{Adjusted EBITDA margin} = \frac{\$12,696 \text{ million}}{\$64,968 \text{ million}} = 19.5\%

\]

This is a system-level profitability measure, not a facility-level margin. It is useful because HCA’s EBITDA includes corporate overhead, interest expense is excluded, and depreciation/amortization is added back. The result is consistent with a capital-intensive hospital business that carries high fixed costs and must maintain high facility-level volume.

Source for adjusted EBITDA: HCA FY2023 10-K, accession no. 0001628280-24-004687, filed 2024-02-16, accessed 2025-05-20.

HCA does not present a traditional “gross margin” in the same way a retailer or manufacturer does; hospital revenue is recognized after contractual allowances, and the main cost categories are salaries and benefits, supplies, other operating expenses, depreciation, and interest.

Calculated net margin for FY2023:

\[

\frac{\$5,242 \text{ million}}{\$64,968 \text{ million}} = 8.1\%

\]

Calculated adjusted EBITDA margin for FY2023:

\[

19.5\%

\]

Both are derived from the FY2023 10-K figures above. They are derived calculations from primary-source inputs but are [SINGLE-SOURCE] because they rely on HCA’s own reported figures.

HCA Healthcare is a large hospital system and therefore a major buyer of CT/MRI/ultrasound capital equipment

• HCA Healthcare is a large hospital system and therefore a major buyer of CT/MRI/ultrasound capital equipment source
• HCA Healthcare, Inc. — SEC EDGAR company filings source

The “derived” figures are arithmetic outputs from primary-source inputs. They are not independently corroborated unless separately matched to an outside source.